Alexandra Pecci from Pharma Voice - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	Alexandra Pecci Pharma Voice Leading community for life sciences leaders. Washington, D.C. pharmaceuticalslife sciencescommunity building		How a 15-year-old Genzyme drug shortage became a legal smorgasbord of pharma’s thorniest issues - 10 months ago Ferring’s microbiome and gene therapy firsts take the company beyond reproductive health - 10 months ago 4 biotechs to watch in 2024 - 10 months ago ‘Hey, AI: Is Zoloft effective for me?’ Tech’s foray into predictive prescribing - 11 months ago Why a former BMS exec calls her new CEO role ‘unfinished business’ in cancer care - 11 months ago Government hits patent thickets on multiple fronts - 11 months ago FDA looks to execute ‘largest reorganization in history’ this year - 11 months ago The hunt for an elusive universal coronavirus vaccine - 11 months ago An enduring COVID mystery: Why some do fine and others die - 11 months ago FDA chief says agency can’t manage health tech alone - 12 months ago Why J&J rebranded its iconic logo - 12 months ago 5 noteworthy pharma AI investments in 2023 - about 1 year ago Rise of the chief investment officer: Why the unique role works for Roivant - about 1 year ago Study suggests PBMs are gaming pharmacy system to overcharge for drugs - about 1 year ago Patients who hide pills and advocacy offices that could get ‘raided’ — a Gilead leader on navigating global HIV - about 1 year ago 4 historic FDA approvals from 2023 - about 1 year ago The fortunes and flops of pharma M&A - about 1 year ago Biopharma’s top 5 IPOs of 2023 (so far) - about 1 year ago How EMD Serono plans to hit its lofty goals in R&D - about 1 year ago The biopharma COO’s playbook - about 1 year ago The power of genomics-based healthcare remains largely untapped - about 1 year ago 6 ways to improve clinical trial diversity — as shown by J&J - about 1 year ago 5 of the best paid biopharma CEOs - about 1 year ago 23andMe CEO Anne Wojcicki’s vision for changing healthcare as a ‘full-fledged biotech’ - about 1 year ago In a record year for biotech bankruptcy, here are 3 companies that went under - about 1 year ago Wisp’s ‘bold and unapologetic approach’ to women’s sexual and reproductive health - about 1 year ago Red Jacket: Ken Getz, a champion of clinical trials - about 1 year ago Red Jacket: Dr. Mark Goldberg, a clinical innovator - about 1 year ago Cidara’s J&J-partnered immunotherapy could target flu and cancer - about 1 year ago For women’s health, Organon changed the financial language - about 1 year ago The FDA might yank cold medicines from shelves — and that could be just the beginning - about 1 year ago To close the pediatric innovation gap, this biotech has to think differently - about 1 year ago Where have all the unicorns gone? A look at 4 billion-dollar biotechs - about 1 year ago What happened to ivermectin? - over 1 year ago